Enterprise Value

597.1M

Cash

292.1M

Avg Qtr Burn

-10.64M

Short % of Float

12.82%

Insider Ownership

2.82%

Institutional Own.

53.60%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date